Filter News
Area of Research
- (-) Neutron Science (37)
- (-) Nuclear Science and Technology (6)
- Advanced Manufacturing (5)
- Biological Systems (1)
- Biology and Environment (125)
- Biology and Soft Matter (1)
- Building Technologies (2)
- Clean Energy (145)
- Climate and Environmental Systems (5)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (15)
- Electricity and Smart Grid (1)
- Energy Sciences (1)
- Functional Materials for Energy (1)
- Fusion and Fission (7)
- Fusion Energy (3)
- Isotopes (7)
- Materials (90)
- Materials for Computing (19)
- Mathematics (1)
- National Security (32)
- Quantum information Science (9)
- Sensors and Controls (1)
- Supercomputing (128)
News Topics
- (-) Big Data (2)
- (-) Biomedical (13)
- (-) Clean Water (2)
- (-) Computer Science (15)
- (-) Environment (8)
- (-) Microscopy (3)
- (-) Polymers (1)
- (-) Quantum Science (7)
- (-) Security (2)
- (-) Sustainable Energy (3)
- 3-D Printing/Advanced Manufacturing (10)
- Advanced Reactors (11)
- Artificial Intelligence (6)
- Bioenergy (7)
- Biology (5)
- Biotechnology (1)
- Chemical Sciences (2)
- Climate Change (1)
- Composites (1)
- Coronavirus (9)
- Cybersecurity (2)
- Decarbonization (3)
- Energy Storage (6)
- Fossil Energy (1)
- Frontier (1)
- Fusion (9)
- High-Performance Computing (2)
- Isotopes (5)
- Machine Learning (3)
- Materials (14)
- Materials Science (26)
- Mathematics (1)
- Molten Salt (4)
- Nanotechnology (10)
- National Security (2)
- Neutron Science (101)
- Nuclear Energy (38)
- Physics (10)
- Quantum Computing (1)
- Space Exploration (8)
- Summit (6)
- Transformational Challenge Reactor (3)
- Transportation (5)
Media Contacts
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.